5 results about "Lactobacillus helveticum" patented technology

The present application provides an immunostimulant containing Lactobacillus helveticus, wherein the Lactobacillus helveticus has three functions: activation of dendritic cell-like cells, induction of immunoglobulin A (IgA) production, and induction of interleukin-12 (IL-12) production.

The application discloses a high-ethanol-tolerant Lactobacillus helveticus and application thereof. The Lactobacillus helveticus is named Lactobacillus helveticus FJL4-UV4, and the preservation number is GDMCC NO.62957. The Lactobacillus helveticus is obtained by ultraviolet mutagenesis of a wild Lactobacillus helveticus FJL4 isolated from a Chinese rice liquor fermentation liquor. The Lactobacillus helveticus FJL4-UV4 provided by the application overcomes the defects of the wild Lactobacillus helveticus FJL4 in high-ethanol tolerance, and promotes the generation of ethyl lactate under high-ethanol conditions. The Lactobacillus helveticus FJL4-UV4 is used for solving the problem of low ethyl lactate content in the fermentation liquor in the Chinese rice liquor production process, and the ability of the Lactobacillus helveticus FJL4-UV4 in increasing the ethyl lactate content in the fermentation liquor is significantly improved compared with the wild type.

This invention belongs to the field of microbial technology, specifically relating to the application of *Lactobacillus helveticus* ZJUIDS12 in preventing and treating microplastic-induced injuries in pets. This invention discloses the application of *Lactobacillus helveticus* ZJUIDS12 in the preparation of drugs for preventing and treating microplastic-induced injuries in pets. The accession number for *Lactobacillus helveticus* ZJUIDS12 is CGMCC NO.23997. The prevention and treatment of microplastic-induced injuries in pets includes: preventing intestinal damage caused by microplastics and preventing fetal growth restriction caused by microplastics.

This invention provides a composition containing lactic acid bacteria and its use in lowering dihydrotestosterone and improving hyperandrogenemia. The composition can lower dihydrotestosterone and improve androgenemia. The lactic acid bacteria comprise *Lactobacillus helveticus* GKS3, *Lactobacillus brevis* GKL9, *Lactobacillus johnsonii* GKJ2, *Pediococcus acidilactici* GKA4, or a combination thereof.

This application belongs to the field of microbial technology and discloses a low-temperature resistant Lactobacillus and Lactococcus compound inoculant and its application in oat silage. This low-temperature resistant Lactobacillus and Lactococcus compound inoculant includes Lactobacillus helveticus T3, Lactobacillus fermentum 1761, and Enterococcus faecalis CTB. This low-temperature resistant, high-performance Lactobacillus and Lactococcus compound inoculant not only maintains stable and efficient functional activity in extreme environments of 5℃ to -20℃, but also rapidly establishes an acidic environment during silage in natural environments (-20℃ to 17℃), effectively inhibiting protein degradation and putrefactive microbial activity, releasing more nutrients, improving silage stability and preservation, and further enhancing fermentation efficiency. Simultaneously, it has lower costs, good economic viability and prospects for large-scale application, providing a reliable and innovative technical solution for the efficient resource utilization of high-fiber raw materials in high-altitude and cold regions.